We Are Eroding The Vital link Between Academic Research And Education

I wonder if what I’ve noticed happening to the faculty of United States medical schools applies equally to other segments of the “research university.” Put simply, we are creating two faculties: one devoted to bringing in research grants and publishing as many papers as possible, and the other relegated to handling the teaching load. The separation is not complete, but it is rapidly becoming so, and the vigor of the latter group is not increasing. Many professors will retire in

Written byDouglas Kelly
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

I wonder if what I’ve noticed happening to the faculty of United States medical schools applies equally to other segments of the “research university.” Put simply, we are creating two faculties: one devoted to bringing in research grants and publishing as many papers as possible, and the other relegated to handling the teaching load. The separation is not complete, but it is rapidly becoming so, and the vigor of the latter group is not increasing. Many professors will retire in the next decade or so. And when this happens, replacements of quality and dedication will be tough to find as their mission becomes even less prestigious.

Many academic health centers have become increasingly concerned more with their rank in the institutional hierarchy of federal or foundation dollars gained than with the quality of education provided. In medical schools, an additional and more recent ingredient is involved—and indeed is essential for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies